Otto, R.; Detjen, K.M.; Riemer, P.; Fattohi, M.; Grötzinger, C.; Rindi, G.; Wiedenmann, B.; Sers, C.; Leser, U.
Transcriptomic Deconvolution of Neuroendocrine Neoplasms Predicts Clinically Relevant Characteristics. Cancers 2023, 15, 936.
https://doi.org/10.3390/cancers15030936
AMA Style
Otto R, Detjen KM, Riemer P, Fattohi M, Grötzinger C, Rindi G, Wiedenmann B, Sers C, Leser U.
Transcriptomic Deconvolution of Neuroendocrine Neoplasms Predicts Clinically Relevant Characteristics. Cancers. 2023; 15(3):936.
https://doi.org/10.3390/cancers15030936
Chicago/Turabian Style
Otto, Raik, Katharina M. Detjen, Pamela Riemer, Melanie Fattohi, Carsten Grötzinger, Guido Rindi, Bertram Wiedenmann, Christine Sers, and Ulf Leser.
2023. "Transcriptomic Deconvolution of Neuroendocrine Neoplasms Predicts Clinically Relevant Characteristics" Cancers 15, no. 3: 936.
https://doi.org/10.3390/cancers15030936
APA Style
Otto, R., Detjen, K. M., Riemer, P., Fattohi, M., Grötzinger, C., Rindi, G., Wiedenmann, B., Sers, C., & Leser, U.
(2023). Transcriptomic Deconvolution of Neuroendocrine Neoplasms Predicts Clinically Relevant Characteristics. Cancers, 15(3), 936.
https://doi.org/10.3390/cancers15030936